CONSTELLATION PHARMACEUTICALS INC: cash_and_restricted_cash
| Value | {"amount": 37162000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | current |
| Entity | CONSTELLATION PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:05:39.010737+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6c260e53-f06b-4cb4-9761-d90929d7a84c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-18-248533Retrieved: 2026-08-19T14:05:39.010737+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001434418/cash-and-restricted-cash/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6c260e53-f06b-4cb4-9761-d90929d7a84c
History
- no predecessors — first report